FDA
-
-
-
-
-
-
-
Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting
-
-
-
-
-
-
-
Genprex signs research deal with MD Anderson to study lung cancer biomarkers
-
-
-
-
-
-
-
Genprex receives Japanese and EU patents for cancer gene therapy combinations
-
-
-
-
-
-
-
Genprex publishes phase 1 lung cancer gene therapy trial data
-
-
-
-
-
-
-
Genprex raises $3.4 million in registered direct offering
-
-
-
-
-
-
-
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EROTC International Conference on Molecular Target
-
-
-
-
-
-
-
Genprex (GNPX) Collaborators Present Positive Preclinical Research on Diabetes Gene Therapy
-
324,763 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

